Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)

Clinical trial NCT04026113 · COMPLETED

Trial details

NCT number: NCT04026113
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Functional Constipation Irritable Bowel Syndrome With Constipation

Start date: 2019-10-01
Primary completion: 2024-05-20
Enrollment: 438

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.